Lakeland Industries (NASDAQ:LAKE) Upgraded to "Sell" at StockNews.com

Lakeland Industries (NASDAQ:LAKE - Get Free Report) was upgraded by research analysts at StockNews.com to a "sell" rating in a research note issued to investors on Wednesday.

Several other equities research analysts also recently commented on the company. Lake Street Capital started coverage on Lakeland Industries in a report on Tuesday, March 11th. They set a "buy" rating and a $30.00 target price on the stock. DA Davidson dropped their target price on Lakeland Industries from $28.00 to $23.00 and set a "buy" rating on the stock in a report on Tuesday, April 15th. One investment analyst has rated the stock with a sell rating and four have given a buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $27.00.

Lakeland Industries Trading Up 4.4%

LAKE traded up $0.75 during trading on Wednesday, hitting $17.81. 5,021 shares of the company's stock were exchanged, compared to its average volume of 63,021. The stock has a 50 day moving average price of $18.07 and a 200 day moving average price of $21.33. Lakeland Industries has a 1 year low of $14.58 and a 1 year high of $27.28. The company has a current ratio of 4.23, a quick ratio of 1.77 and a debt-to-equity ratio of 0.25. The firm has a market cap of $169.39 million, a P/E ratio of -200.06 and a beta of 1.10.

Lakeland Industries (NASDAQ:LAKE - Get Free Report) last released its quarterly earnings data on Wednesday, April 9th. The medical instruments supplier reported ($0.54) EPS for the quarter, missing the consensus estimate of $0.43 by ($0.97). Lakeland Industries had a negative net margin of 0.42% and a positive return on equity of 1.66%. The company had revenue of $46.60 million during the quarter, compared to analysts' expectations of $47.10 million. During the same period last year, the business earned $0.72 earnings per share. As a group, analysts expect that Lakeland Industries will post 0.48 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of the business. Evernest Financial Advisors LLC bought a new position in shares of Lakeland Industries in the first quarter worth $1,348,000. Pacific Ridge Capital Partners LLC grew its holdings in Lakeland Industries by 3.8% during the first quarter. Pacific Ridge Capital Partners LLC now owns 297,962 shares of the medical instruments supplier's stock worth $6,052,000 after acquiring an additional 10,992 shares during the period. Jefferies Financial Group Inc. grew its holdings in Lakeland Industries by 4.5% during the first quarter. Jefferies Financial Group Inc. now owns 20,348 shares of the medical instruments supplier's stock worth $413,000 after acquiring an additional 883 shares during the period. Royce & Associates LP lifted its holdings in shares of Lakeland Industries by 9.4% during the first quarter. Royce & Associates LP now owns 931,920 shares of the medical instruments supplier's stock valued at $18,927,000 after purchasing an additional 79,940 shares during the last quarter. Finally, Delta Investment Management LLC purchased a new stake in shares of Lakeland Industries during the fourth quarter valued at $445,000. Institutional investors own 71.69% of the company's stock.

About Lakeland Industries

Lakeland Industries, Inc manufactures and sells industrial protective clothing and accessories for the industrial and public protective clothing market worldwide. It offers firefighting and heat protective apparel to protect against fire; high-end chemical protective suits to provide protection from highly concentrated, toxic and/or lethal chemicals, and biological toxins; and limited use/disposable protective clothing, such as coveralls, laboratory coats, shirts, pants, hoods, aprons, sleeves, arm guards, caps, and smocks.